GSK Q3 Net Profit Falls 23% on Restructuring Costs; FY Guidance Maintained

GSK reported a 23% year-on-year decline in Q3 net profit, driven by £328 million in restructuring costs tied to a savings program targeting £1.9 billion annual savings by 2029. The company maintained its full-year guidance, indicating the profit drop is a one-off cost impact rather than an operational deterioration. This is a company-specific earnings event with limited macro market implications.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works